MEETINGS - Seminar on Biotechnology products: From the science to the market (UK) February 2001:
This article was originally published in Clinica
Executive Summary
The Department of Biosciences, Warwick University, UK, and GMG Biobusiness will hold a seminar entitled Biotechnology products: from the science to the market, at Warwick University on February 11-13. Topics for discussion will include: discovering better medicines through genetics; application of immunology to oncology; preclinical development of biotechnology products; European regulatory challenges and requirements; and reviewing EU product approvals: 1995-2000. For more information contact Charlotte West at Warwick University. Tel: +44 (0) 24 7652 3540. Fax: +44 (0) 24 7652 3701. Email: [email protected]
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.